Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
96 Cr
High Risk
17.8
30.8
0.1
2.6
147.90
107.00
Sales CAGR
1Y
38.16%
3Y
27.43%
5Y
—
10Y
—
Profit CAGR
1Y
25.46%
3Y
131.45%
5Y
—
10Y
—
ROE
TTM
—
3Y
57.08%
5Y
—
10Y
—
ROCE
TTM
—
3Y
40.10%
5Y
—
10Y
—
Bearish
4
Neutral
5
Bullish
5
Bearish
16
Neutral
25
Bullish
5
Bearish
12
Neutral
20
Bullish
0
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Market Cap
₹ 96 Cr
P/E
17.83
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
EXCEPTIONAL
Profitability
MODERATE MARGIN
Technicals
Neutral
Risk
HIGH RISK